Scibase Holding AB — Investor Relations & Filings

SciBase is a medical technology company focused on the early detection and prevention of skin disorders. The company develops, manufactures, and commercializes the Nevisense platform, a point-of-care system that utilizes Electrical Impedance Spectroscopy (EIS) combined with AI-powered algorithms. This non-invasive technology provides clinicians with objective, actionable data to improve diagnostic accuracy for skin cancer, particularly melanoma, and reduce unnecessary biopsies. The platform is also used for skin barrier assessment in research and cosmetic testing to monitor therapeutic improvements, disease progression, and subclinical inflammation. The underlying technology is based on more than two decades of research conducted at the Karolinska Institute.